Tomoyuki Kanda

Combined Use of the Adenosine A2A Antagonist KW-6002 with l-DOPA or with Selective D1 or D2 Dopamine Agonists Increases Antiparkinsonian Activity but Not Dyskinesia in MPTP-Treated Monkeys

Tomoyuki Kanda, Lance A. Smith, R. K. B. Pearce et al. · Experimental Neurology · 2000 · 246 citations

Life Sciences, Neuroscience, Pharmacology +15

KF17837: A novel selective adenosine A2A receptor antagonist with anticataleptic activity

Tomoyuki Kanda, Shizuo Shiozaki, Junichi Shimada et al. · European Journal of Pharmacology · 1994 · 146 citations

Medicine, Medicinal Chemistry, Pharmacology +5

Topiramate reduces abnormally high extracellular levels of glutamate and aspartate in the hippocampus of spontaneously epileptic rats (SER)

Tomoyuki Kanda, Masako Kurokawa, Sachiko Tamura et al. · Life Sciences · 1996 · 69 citations

Life Sciences, Neurobiology, Neuroscience +13

FMRFamide-related peptides isolated from the prosobranch mollusc Fusinus ferrugineus.

Yoshihiro Kuroki, Tomoyuki Kanda, I. Kubota et al. · PubMed · 1993 · 31 citations

Life Sciences, Biochemistry, Marine Biology +5